MAXIPIME Side Effects

7014808-X | Interstitial Lung Disease
on Sep 22, 2010 Female patient from JAPAN , 62 years of age, was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Maxipime dosage: . During the same period patient was treated with NEU UP (View Neu-up Review and Neu-up Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), ONCOVIN (View Oncovin Review and Oncovin Label ).

6936960-4 | Confusional State, Hallucination, Visual, Urinary Tract Infection, Urine Output Decreased
Patient was taking Maxipime (View Usage). Patient had the following side effects: confusional state, hallucination, visual, urinary tract infection (What is urinary tract infection?), urine output decreased on Jan 05, 2010 from UNITED STATES Additional patient health information: Female patient , 83 years of age, . Maxipime dosage: .

6936958-6 | Nausea
Adverse event was reported on Oct 16, 2009 by a Female patient taking Maxipime (View Usage) (Dosage: ) . Location: JAPAN , 92 years of age, After Maxipime was administered, patient had the following side effects: nausea (What is nausea?).

6935998-0 | Disseminated Intravascular Coagulation, Intestinal Obstruction, Pseudomembranous Colitis
on Aug 18, 2010 Male patient from JAPAN , 74 years of age, was diagnosed with febrile neutropenia and was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: disseminated intravascular coagulation, intestinal obstruction, pseudomembranous colitis. Maxipime dosage: . Patient was hospitalized.


6918961-5 | Disseminated Intravascular Coagulation, Intestinal Obstruction, Pseudomembranous Colitis
on Aug 04, 2010 Male patient from JAPAN , 74 years of age, was diagnosed with febrile neutropenia and was treated with Maxipime (View Usage). Patient had the following side effects: disseminated intravascular coagulation, intestinal obstruction, pseudomembranous colitis. Maxipime dosage: .

6918806-3 | Anaemia, Haemorrhage, Thrombocytopenia
Patient was taking Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: anaemia, haemorrhage, thrombocytopenia on Jul 30, 2010 from JAPAN Additional patient health information: Male patient , 74 years of age, weighting 108.0 lb, was diagnosed with prophylaxis and. Maxipime dosage: 1gm/day:iv:02feb2010:1 Day 1gx2/d From 28jan10 To 31jan10 (4d). During the same period patient was treated with MIRACLID (View Miraclid Review and Miraclid Label ), PANTHENOL (View Panthenol Review and Panthenol Label ), OMEPRAL (View Omepral Review and Omepral Label ), AMINO ACID+CARBOHYDRATE+ELECTROLYTE+VITAMINS (View Amino Acid+carbohydrate+electrolyte+vitamins Review and Amino Acid+carbohydrate+electrolyte+vitamins Label ). Patient was hospitalized.

6909064-4 | Pneumonia
Adverse event was reported on Jul 29, 2010 by a Female patient taking Maxipime (View Usage) (Dosage: ) . Location: JAPAN , 31 years of age, Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ), FIRSTCIN (View Firstcin Review and Firstcin Label ).

6843718-3 | Altered State Of Consciousness, Myoclonus, Rash
on Jul 06, 2010 Female patient from JAPAN , 85 years of age, weighting 92.59 lb, was diagnosed with osteomyelitis and was treated with Maxipime (View Usage). Patient had the following side effects: altered state of consciousness, myoclonus, rash (What is rash?). Maxipime dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), DALACIN (View Dalacin Review and Dalacin Label ). Patient was hospitalized.

6836459-X | Altered State Of Consciousness, Dyskinesia, Encephalopathy
on Jul 06, 2010 Male patient from JAPAN , 89 years of age, was diagnosed with cholangitis and was treated with Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: altered state of consciousness, dyskinesia, encephalopathy. Maxipime dosage: . During the same period patient was treated with DALACIN (View Dalacin Review and Dalacin Label ). Patient was hospitalized.

6815281-4 | Altered State Of Consciousness, Dyskinesia, Toxic Encephalopathy
Patient was taking Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, dyskinesia, toxic encephalopathy on Jun 29, 2010 from JAPAN Additional patient health information: Female patient , 85 years of age, was diagnosed with osteomyelitis and. Maxipime dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ). Patient was hospitalized.

6791036-4 | Altered State Of Consciousness, Dyskinesia, Tremor
Adverse event was reported on Jun 18, 2010 by a Female patient taking Maxipime (View Usage) (Dosage: Discontinued On 19jan10 Other Dose: 1g Qd Iv Drip) was diagnosed with sepsis (What is sepsis?) and. Location: JAPAN , 64 years of age, weighting 110.2 lb, Patient had the following side effects: altered state of consciousness, dyskinesia, tremor. During the same period patient was treated with MEROPEN (Interrupted On 17jan10 Other Dose:0.5g Qd Ivdrip) (View Meropen Review and Meropen Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6771339-X | Altered State Of Consciousness, Dyskinesia, Tremor
on Jun 07, 2010 Female patient from JAPAN , 64 years of age, weighting 110.2 lb, was diagnosed with sepsis (What is sepsis?) and was treated with Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: altered state of consciousness, dyskinesia, tremor. Maxipime dosage: Discontinued On 19jan10 Other Dose: 1g Qd Iv Drip. During the same period patient was treated with MEROPEN (Interrupted On 17jan10 Other Dose:0.5g Qd Ivdrip) (View Meropen Review and Meropen Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6765927-4 | Altered State Of Consciousness, Dyskinesia, Toxic Encephalopathy
on Jun 02, 2010 Female patient from JAPAN , 85 years of age, was diagnosed with osteomyelitis and was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, dyskinesia, toxic encephalopathy. Maxipime dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ). Patient was hospitalized.

6739961-4 | Blood Pressure Decreased
Patient was taking Maxipime (View Usage). Patient had the following side effects: blood pressure decreased on May 21, 2010 from JAPAN Additional patient health information: Male patient , 57 years of age, was diagnosed with pyrexia and. Maxipime dosage: .

6732573-8 | Blood Pressure Decreased
Adverse event was reported on May 11, 2010 by a Male patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with pyrexia and. Location: JAPAN , 57 years of age, After Maxipime was administered, patient had the following side effects: blood pressure decreased.

6700750-8 | Stevens-johnson Syndrome, Toxic Skin Eruption
on Apr 23, 2010 Male patient from JAPAN , 71 years of age, weighting 165.3 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome, toxic skin eruption. Maxipime dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6700046-4 | Bile Duct Obstruction, Liver Function Test Abnormal
on Apr 22, 2010 Male patient from UNITED STATES , 58 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Maxipime (View Usage). Patient had the following side effects: bile duct obstruction, liver function test abnormal. Maxipime dosage: The Patient Received 4 Doses..

6688801-0 | Altered State Of Consciousness
Patient was taking Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: altered state of consciousness on Apr 14, 2010 from JAPAN Additional patient health information: Female patient , 66 years of age, was diagnosed with infection (What is infection?) and. Maxipime dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

6670854-7 | Pulmonary Haemorrhage, Shock
Adverse event was reported on Mar 30, 2010 by a Male patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with leptospirosis and. Location: JAPAN , 54 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: pulmonary haemorrhage, shock. Patient was hospitalized.

6655265-2 | Rash, Stevens-johnson Syndrome
on Mar 22, 2010 Female patient from CZECH REPUBLIC , 39 years of age, was diagnosed with skin infection and was treated with Maxipime (View Usage). Patient had the following side effects: rash (What is rash?), stevens-johnson syndrome. Maxipime dosage: . During the same period patient was treated with PROSTAPHLIN INJ 1 G (View Prostaphlin Inj 1 G Review and Prostaphlin Inj 1 G Label ).

6645426-0 | Pulmonary Haemorrhage, Shock
on Mar 10, 2010 Male patient from JAPAN , 54 years of age, weighting 165.3 lb, was diagnosed with leptospirosis and was treated with Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: pulmonary haemorrhage, shock. Maxipime dosage: . Patient was hospitalized.

6618768-2 | Atrial Fibrillation, Chronic Obstructive Pulmonary Disease, Coronary Artery Disease, Gastrointestinal Haemorrhage, Hypertension, Lumbar Vertebral Fracture, Rectocele, Renal Failure, Respiratory Failure
Patient was taking Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), chronic obstructive pulmonary disease, coronary artery disease (What is coronary artery disease?), gastrointestinal haemorrhage, hypertension, lumbar vertebral fracture, rectocele, renal failure, respiratory failure on Mar 01, 2010 from CHINA Additional patient health information: Female patient , 72 years of age, was diagnosed with pneumonia (What is pneumonia?) and. Maxipime dosage: 2 Gram Per Day.

6574648-2 | Blood Bilirubin Increased
Adverse event was reported on Feb 03, 2010 by a Female patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with cellulitis (What is cellulitis?) and. Location: UNITED STATES , 58 years of age, Patient had the following side effects: blood bilirubin increased.

6568520-1 | Blood Bilirubin Increased, Cholecystitis
on Jan 28, 2010 Female patient from UNITED STATES , 58 years of age, was diagnosed with cellulitis (What is cellulitis?) and was treated with Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: blood bilirubin increased, cholecystitis. Maxipime dosage: .

6500508-9 | Haematuria
on Dec 04, 2009 Male patient from CHINA , 72 years of age, was diagnosed with asthma (What is asthma?) and was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: haematuria. Maxipime dosage: With 5% Glucose Injection 200ml. During the same period patient was treated with DOXOFYLLINE (With 5% Glucose Injection 200ml) (View Doxofylline Review and Doxofylline Label ), 5% GLUCOSE (Inj.) (View 5% Glucose Review and 5% Glucose Label ).

6450377-0 | Haemolytic Anaemia, Platelet Count Increased
Patient was taking Maxipime (View Usage). Patient had the following side effects: haemolytic anaemia, platelet count increased on Nov 16, 2009 from UNITED STATES Additional patient health information: Female patient , 63 years of age, was diagnosed with infection (What is infection?) and. Maxipime dosage: .

6424473-8 | Activated Partial Thromboplastin Time Prolonged, Haematuria
Adverse event was reported on Oct 30, 2009 by a Male patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with lower respiratory tract infection, pneumonia aspiration and. Location: INDIA , 34 years of age, After Maxipime was administered, patient had the following side effects: activated partial thromboplastin time prolonged, haematuria.

6424471-4 | Activated Partial Thromboplastin Time Prolonged, Haematuria
on Oct 30, 2009 Male patient from INDIA , 79 years of age, was diagnosed with pneumonia (What is pneumonia?), acute respiratory distress syndrome and was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, haematuria. Maxipime dosage: Reduced To 1gm Every 8hours On 5th Day. During the same period patient was treated with BRISTOKACIN (View Bristokacin Review and Bristokacin Label ).

6424470-2 | Haematuria
on Oct 30, 2009 Male patient from INDIA , 62 years of age, was diagnosed with acute respiratory distress syndrome and was treated with Maxipime (View Usage). Patient had the following side effects: haematuria. Maxipime dosage: .

6368235-9 | Hypoaesthesia, Vision Blurred
Patient was taking Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: hypoaesthesia, vision blurred on Sep 18, 2009 from UNITED STATES Additional patient health information: Male patient , 58 years of age, . Maxipime dosage: .

6357726-2 | Hypoaesthesia, Vision Blurred
Adverse event was reported on Sep 14, 2009 by a Male patient taking Maxipime (View Usage) (Dosage: ) . Location: UNITED STATES , 58 years of age, Patient experienced the following unwanted or unexpected effects: hypoaesthesia, vision blurred.

6355052-9 | Aphasia, Apraxia, Coordination Abnormal
on Sep 10, 2009 Female patient from GERMANY , 89 years of age, weighting 147.7 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Maxipime (View Usage). Patient had the following side effects: aphasia (What is aphasia?), apraxia, coordination abnormal. Maxipime dosage: Morning. Patient was hospitalized.

6355051-7 | Aphasia, Apraxia, Coordination Abnormal
on Sep 10, 2009 Female patient from GERMANY , 89 years of age, weighting 147.7 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: aphasia (What is aphasia?), apraxia, coordination abnormal. Maxipime dosage: Morning.

6296626-3 | Liver Disorder, Stevens-johnson Syndrome
Patient was taking Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder, stevens-johnson syndrome on Jul 30, 2009 from JAPAN Additional patient health information: Male patient , 23 years of age, . Maxipime dosage: .

6272485-X | Aphasia, Apraxia, Coordination Abnormal
Adverse event was reported on Jul 15, 2009 by a Female patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?) and. Location: GERMANY , 89 years of age, weighting 147.7 lb, Patient had the following side effects: aphasia (What is aphasia?), apraxia, coordination abnormal.

6218244-5 | Aphasia, Apraxia
on Jun 04, 2009 Female patient from GERMANY , 89 years of age, weighting 147.7 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: aphasia (What is aphasia?), apraxia. Maxipime dosage: . Patient was hospitalized.

6130872-4 | Altered State Of Consciousness, Blood Creatinine Increased, Cardiac Failure, Myoclonus, Renal Failure Chronic
on Mar 19, 2009 Female patient from JAPAN , 75 years of age, was diagnosed with pyrexia, infection (What is infection?) and was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, blood creatinine increased, cardiac failure, myoclonus, renal failure chronic. Maxipime dosage: . During the same period patient was treated with THYRADIN S (View Thyradin S Review and Thyradin S Label ), LASIX (View Lasix Review and Lasix Label ), ALFAROL (View Alfarol Review and Alfarol Label ), ADALAT (View Adalat Review and Adalat Label ), GLAKAY (View Glakay Review and Glakay Label ), BASEN (View Basen Review and Basen Label ), MARZULENE S (View Marzulene-s Review and Marzulene-s Label ). Patient was hospitalized.

6110951-8 | Transaminases Increased
Patient was taking Maxipime (View Usage). Patient had the following side effects: transaminases increased on Mar 09, 2009 from SPAIN Additional patient health information: Male patient , 79 years of age, was diagnosed with bronchiectasis, bronchopulmonary aspergillosis and. Maxipime dosage: 1 Gram Powder Iv Solution - 1 Vial+ 1 Ampule. During the same period patient was treated with TAVANIC (500 Mg Coated Tablets-10 Tablets) (View Tavanic Review and Tavanic Label ), VFEND (28 Coated Tablets) (View Vfend Review and Vfend Label ). Patient was hospitalized.

6086536-9 | Stevens-johnson Syndrome
Adverse event was reported on Feb 17, 2009 by a Male patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with febrile neutropenia, lymphoma (What is lymphoma?) and. Location: JAPAN , 45 years of age, After Maxipime was administered, patient had the following side effects: stevens-johnson syndrome. During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), RITUXAN (View Rituxan Review and Rituxan Label ), TOBRACIN (View Tobracin Review and Tobracin Label ), LASTET (View Lastet Review and Lastet Label ), DECADRON (View Decadron Review and Decadron Label ), CYLOCIDE (View Cylocide Review and Cylocide Label ), PENTCILLIN (View Pentcillin Review and Pentcillin Label ), AMIKACIN SULFATE (View Amikacin Sulfate Review and Amikacin Sulfate Label ). Patient was hospitalized.

6035446-1 | Hepatic Function Abnormal, Multi-organ Failure
on Jan 09, 2009 Male patient from JAPAN , 87 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, multi-organ failure. Maxipime dosage: .

5999291-5 | Asphyxia, Muscle Spasms
on Dec 09, 2008 Male patient from CHINA , 92 years of age, was diagnosed with lung infection and was treated with Maxipime (View Usage). Patient had the following side effects: asphyxia, muscle spasms. Maxipime dosage: .

5909820-5 | Stevens-johnson Syndrome
Patient was taking Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: stevens-johnson syndrome on Oct 06, 2008 from JAPAN Additional patient health information: Male patient , 46 years of age, . Maxipime dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CYLOCIDE (View Cylocide Review and Cylocide Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), RITUXAN (View Rituxan Review and Rituxan Label ).

5890542-4 | Stevens-johnson Syndrome
Adverse event was reported on Sep 17, 2008 by a Male patient taking Maxipime (View Usage) (Dosage: ) . Location: JAPAN , 46 years of age, Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome. During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CYLOCIDE (View Cylocide Review and Cylocide Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), RITUXAN (View Rituxan Review and Rituxan Label ).

5885847-7 | Altered State Of Consciousness, Dyskinesia
on Sep 16, 2008 Female patient from JAPAN , 85 years of age, was diagnosed with osteomyelitis and was treated with Maxipime (View Usage). Patient had the following side effects: altered state of consciousness, dyskinesia. Maxipime dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ). Patient was hospitalized.

5874694-8 | Anuria, Coma, Encephalopathy, Febrile Neutropenia, Renal Failure, Septic Shock
on Sep 05, 2008 Male patient from BELGIUM , 72 years of age, was diagnosed with febrile neutropenia and was treated with Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: anuria, coma, encephalopathy, febrile neutropenia, renal failure, septic shock. Maxipime dosage: . During the same period patient was treated with AMUKIN (View Amukin Review and Amukin Label ), GLAZIDIM (View Glazidim Review and Glazidim Label ). Patient was hospitalized.

5866653-6 | Altered State Of Consciousness, Dyskinesia
Patient was taking Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, dyskinesia on Aug 29, 2008 from JAPAN Additional patient health information: Female patient , 85 years of age, was diagnosed with osteomyelitis and. Maxipime dosage: . During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ).

5854127-8 | Neutrophil Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Oct 19, 2007 by a Male patient taking Maxipime (View Usage) (Dosage: ) was diagnosed with post procedural infection and. Location: UNITED STATES , 60 years of age, Patient had the following side effects: neutrophil count decreased, white blood cell count decreased.

5845431-8 | Pulmonary Embolism
on Jul 24, 1997 Male patient from ITALY , 84 years of age, was diagnosed with pneumonia (What is pneumonia?), deep vein thrombosis (What is deep vein thrombosis?), coronary artery disease (What is coronary artery disease?), hypertensive heart disease, hypertension and was treated with Maxipime (View Usage). After Maxipime was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Maxipime dosage: . During the same period patient was treated with LIQUAEMIN INJ (1 Dosage Form=32000 Units) (View Liquaemin Inj Review and Liquaemin Inj Label ), MODURETIC 5 50 (Duration Value: }1,1 Dosage Form=50/5mg) (View Moduretic 5-50 Review and Moduretic 5-50 Label ), MODURETIC 5 50 (Duration Value: }1,1 Dosage Form=50/5mg) (View Moduretic 5-50 Review and Moduretic 5-50 Label ), DEPONIT 5 (Duration Value: }1) (View Deponit 5 Review and Deponit 5 Label ). Patient was hospitalized.

5837929-3 | Hyperhidrosis, Speech Disorder, Tremor
on Aug 07, 2008 Female patient from CHINA , 70 years of age, was diagnosed with pyrexia, cough and was treated with Maxipime (View Usage). Patient experienced the following unwanted or unexpected effects: hyperhidrosis, speech disorder, tremor. Maxipime dosage: . During the same period patient was treated with PENICILLIN (View Penicillin Review and Penicillin Label ).

5825409-0 | Neutropenia, White Blood Cell Count Decreased
Patient was taking Maxipime (View Usage). Patient had the following side effects: neutropenia, white blood cell count decreased on Jul 25, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 174.0 lb, was diagnosed with post procedural infection, pseudomonas infection and. Maxipime dosage: 2 Grams Every 12 Hours Iv.